GALR2 peptide

  • Check with publisher
  • Published date: June 25, 2019
    • Shirley, New York, United States

Galanin is an important neuromodulator present in the brain, gastrointestinal system, and hypothalamopituitary axis. It is a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific membrane receptors that are members of the 7-transmembrane family of G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq), in contrast to GALR1, which communicates its intracellular signal by inhibition of adenylyl cyclase through Gi. However, it has been demonstrated that GALR2 couples efficiently to both the Gq and Gi proteins to simultaneously activate 2 independent signal transduction pathways. [provided by RefSeq, Jul 2008] https://www.creative-diagnostics.com/GALR2-peptide-180368-436.htm

Thomas Schmitt
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Explore New SAMHSA Confidentiality Law

    Explore New SAMHSA Confidentiality Law

    Clinical/Medical Sciences Fremont (California) January 3, 2020 Check with publisher

    Overview: This lesson will be addressing how practice/business managers (or compliance offers) need to ensure their organization is complying with the Federal Substance Abuse and Mental Health Administration (SAMHSA) regulations (42 CFR Part 2). This...

  • Upcoming Changes with HIPAA -2020

    Upcoming Changes with HIPAA -2020

    Clinical/Medical Sciences Fremont (California) January 3, 2020 Check with publisher

    Overview: This lesson will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order as HIPAA is now fully enforced and the government is not using kid gloves any more. It will also address major chang...

  • Texting and E-mail with Patients: Patient Requests and Complying with HIPAA

    Texting and E-mail with Patients: Patient Requests and Complying with HIPAA

    Clinical/Medical Sciences Fremont (California) January 3, 2020 Check with publisher

    Overview: This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what is an acceptable process for communications with individuals. The session will explain how to discuss co...